Publikation:

TNF: a moonlighting protein at the interface between cancer and infection

Lade...
Vorschaubild

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2008

Autor:innen

Hundsberger, Harald
Verin, Alexander
Wiesner, Christoph
Pflüger, Maren
Dulebo, Alexander
Schütt, Wolfgang
Lasters, Ignace
Männel, Daniela N.
Lucas, Rudolf

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

DOI (zitierfähiger Link)
ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Frontiers in Bioscience. 2008, 13(14), pp. 5374-5386. ISSN 1093-9946. eISSN 1093-4715. Available under: doi: 10.2741/3087

Zusammenfassung

The remarkable ability of TNF, especially in combination with Interferon-gamma or melphalan, to inhibit the growth of malignant tumor cells is so far unmatched. Unfortunately, its high systemic toxicity and hepatotoxicity prevent its systemic use in cancer patients. An elegant manner to circumvent this problem is the isolated limb and liver perfusion for the treatment of melanoma, soft tissue sarcoma and liver tumors, respectively, although the latter method can lead to a reversible hepatotoxicity. In order to allow also the treatment of other cancers with TNF, new strategies have to be developed that aim at sensitizing tumor cells to TNF and at reducing its systemic and liver toxicity, without losing its antitumor efficiency. Moreover, the lectin-like domain of TNF, which is spatially distinct from the receptor binding sites, could be useful in reducing cancer treatment-related pulmonary edema formation. This review will discuss some recent developments in these areas, which can lead to a renewed interest in TNF for the systemic treatment of cancer.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690HUNDSBERGER, Harald, Alexander VERIN, Christoph WIESNER, Maren PFLÜGER, Alexander DULEBO, Wolfgang SCHÜTT, Ignace LASTERS, Daniela N. MÄNNEL, Albrecht WENDEL, Rudolf LUCAS, 2008. TNF: a moonlighting protein at the interface between cancer and infection. In: Frontiers in Bioscience. 2008, 13(14), pp. 5374-5386. ISSN 1093-9946. eISSN 1093-4715. Available under: doi: 10.2741/3087
BibTex
@article{Hundsberger2008moonl-1244,
  year={2008},
  doi={10.2741/3087},
  title={TNF: a moonlighting protein at the interface between cancer and infection},
  number={14},
  volume={13},
  issn={1093-9946},
  journal={Frontiers in Bioscience},
  pages={5374--5386},
  author={Hundsberger, Harald and Verin, Alexander and Wiesner, Christoph and Pflüger, Maren and Dulebo, Alexander and Schütt, Wolfgang and Lasters, Ignace and Männel, Daniela N. and Wendel, Albrecht and Lucas, Rudolf}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/1244">
    <dc:creator>Hundsberger, Harald</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Lucas, Rudolf</dc:contributor>
    <dc:creator>Männel, Daniela N.</dc:creator>
    <dcterms:issued>2008</dcterms:issued>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Männel, Daniela N.</dc:contributor>
    <dc:creator>Dulebo, Alexander</dc:creator>
    <dcterms:title>TNF: a moonlighting protein at the interface between cancer and infection</dcterms:title>
    <dc:contributor>Lasters, Ignace</dc:contributor>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:contributor>Wendel, Albrecht</dc:contributor>
    <dc:contributor>Hundsberger, Harald</dc:contributor>
    <dc:contributor>Pflüger, Maren</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-23T09:07:23Z</dcterms:available>
    <dc:creator>Wiesner, Christoph</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-23T09:07:23Z</dc:date>
    <dc:contributor>Dulebo, Alexander</dc:contributor>
    <dc:creator>Schütt, Wolfgang</dc:creator>
    <dc:creator>Pflüger, Maren</dc:creator>
    <dc:creator>Lasters, Ignace</dc:creator>
    <dc:contributor>Schütt, Wolfgang</dc:contributor>
    <dc:creator>Lucas, Rudolf</dc:creator>
    <dcterms:abstract xml:lang="eng">The remarkable ability of TNF, especially in combination with Interferon-gamma or melphalan, to inhibit the growth of malignant tumor cells is so far unmatched. Unfortunately, its high systemic toxicity and hepatotoxicity prevent its systemic use in cancer patients. An elegant manner to circumvent this problem is the isolated limb and liver perfusion for the treatment of melanoma, soft tissue sarcoma and liver tumors, respectively, although the latter method can lead to a reversible hepatotoxicity. In order to allow also the treatment of other cancers with TNF, new strategies have to be developed that aim at sensitizing tumor cells to TNF and at reducing its systemic and liver toxicity, without losing its antitumor efficiency. Moreover, the lectin-like domain of TNF, which is spatially distinct from the receptor binding sites, could be useful in reducing cancer treatment-related pulmonary edema formation. This review will discuss some recent developments in these areas, which can lead to a renewed interest in TNF for the systemic treatment of cancer.</dcterms:abstract>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/1244"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:bibliographicCitation>Publ. in: Frontiers in Bioscience 13 (2008), 14, pp. 5374-5386</dcterms:bibliographicCitation>
    <dc:creator>Verin, Alexander</dc:creator>
    <dc:language>eng</dc:language>
    <dc:contributor>Wiesner, Christoph</dc:contributor>
    <dc:creator>Wendel, Albrecht</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Verin, Alexander</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen